Indications for acute and chronic dialysis
Two different decisions
- Two entirely different decisions:
- Acute - a life-threatening derangement that will not respond to medical therapy in time
- Chronic - a symptom- and quality-of-life-driven decision, made over months, with an alternative (conservative care)
- *No creatinine, urea or eGFR value by itself is an indication for dialysis*
Epidemiology
- ~5-10% of AKI requires acute RRT; >50% of stage 3 AKI in ICU
- ~2,900 Australians start kidney replacement therapy each year (ANZDATA); median age at start ~60
- ~20% start with a functioning permanent access; the rest start with a catheter - a marker of late referral
What dialysis does and does not do
- Dialysis removes small solutes and water only; the indication is always about a solute or volume problem, not the diagnosis
- Uraemic toxicity is caused by retained middle molecules, guanidines and protein-bound solutes - urea is a marker, not the toxin
- The threshold for dialysis is symptomatic, because uraemic symptoms appear at very different eGFR levels in different people (muscle mass, nutrition, comorbidity)
Acute indications - AEIOU
Acute indications - AEIOU
| Indication | |
|---|---|
| A | Acidosis - metabolic acidosis refractory to bicarbonate, pH <7.1 |
| E | Electrolytes - hyperkalaemia refractory to medical therapy, or with ECG changes |
| I | Intoxication - lithium, salicylate, methanol, ethylene glycol, metformin (lactic acidosis), theophylline, valproate |
| O | Overload - pulmonary oedema unresponsive to diuretics |
| U | Uraemia - pericarditis, encephalopathy, seizures, uraemic bleeding, intractable nausea and vomiting |
- Timing: early ('pre-emptive') initiation does NOT improve survival - STARRT-AKI, AKIKI, ELAIN
- Wait for a true indication; watchful waiting avoids dialysis altogether in a substantial minority
- Also consider in: tumour lysis with refractory hyperkalaemia/hyperphosphataemia, severe hypercalcaemia, hyperthermia, hypothermia
Chronic indications - when to start
Chronic indications - when to start
- Symptoms, not a number
- Uraemic symptoms: nausea, vomiting, anorexia, weight loss, fatigue, pruritus, restless legs, cognitive slowing
- Refractory volume overload or hypertension
- Refractory hyperkalaemia or acidosis
- Malnutrition/declining nutritional status despite dietary intervention
- Pericarditis, encephalopathy, neuropathy - late and should never be reached
- Usually occurs at eGFR 5-10 mL/min/1.73m2
- *IDEAL trial: starting at eGFR 10-14 vs 5-7 gave no survival or quality-of-life benefit* - so start on symptoms
- Prepare at eGFR ~20, or KFRE 2-yr kidney failure risk >10%
Modality selection - lifestyle and comorbidity, not clearance
Modality selection - the axis is lifestyle and comorbidity, not clearance
| Haemodialysis | Peritoneal dialysis | |
|---|---|---|
| Schedule | 4-5 h, 3x/week (in-centre or home) | Daily; CAPD 4 exchanges or APD overnight |
| Suits | No home support, needs supervision, obesity, prior abdominal surgery | Independence, travel, work, preserving residual function, needle phobia, poor cardiac reserve |
| Haemodynamics | Intermittent, hypotension-prone | Gentle, continuous |
| Residual function | Declines faster | Better preserved |
| Diet/fluid | Tighter restrictions | More liberal; protein loss in dialysate |
| Key complication | Access failure, catheter bacteraemia | Peritonitis, encapsulating peritoneal sclerosis, hernia |
- No survival difference overall. PD advantage early, HD later - technique failure limits PD to ~5-8 years
Relative contraindications to peritoneal dialysis
- Peritoneal scarring/adhesions - multiple abdominal operations, prior gallbladder or bowel perforation, adhesive small bowel obstruction
- Active intra-abdominal inflammation or malignancy
- Abdominal wall hernia (repair first), surgical ostomy (exit-site infection risk)
- Ventriculo-peritoneal shunt
- Significant physical, cognitive or psychological impairment without a carer; unsuitable home environment
- Severe respiratory disease (splinting from dwell volume), morbid obesity
- Failure of ultrafiltration in high transporters
Contraindications and cautions for haemodialysis
- Exhausted vascular access; severe cardiac failure intolerant of ultrafiltration; unmanageable coagulopathy
Special situations
- Pregnancy on dialysis - intensify to up to 6 days/week to keep pre-dialysis urea below ~20 mmol/L
- More dialysis = higher live birth rate and gestational age; monitor for hypotension and polyhydramnios
- Haemodynamic instability -> CRRT rather than intermittent HD; slower solute and fluid removal is better tolerated
- Severe hyperkalaemia -> intermittent HD, which corrects faster than CRRT
- First-ever dialysis in severe uraemia -> short, low-efficiency session to avoid disequilibrium syndrome
Preparation for chronic dialysis
- Education and modality choice >=6-12 months before need
- Vein preservation (no cannulas, PICCs or venepuncture in the non-dominant forearm)
- AV fistula ~6 months ahead; PD catheter ~2-4 weeks ahead
- Pre-emptive transplant workup at eGFR 15-20 - pre-emptive transplantation gives the best outcomes
- Hepatitis B vaccination (double dose, 4 doses), influenza, pneumococcal, COVID
Not starting - conservative kidney management
- A legitimate, actively managed pathway: symptom control, anaemia and volume management, advance care planning
- Survival benefit of dialysis is small and may be absent in patients over 75 with high comorbidity or dementia, and hospital-free days may be fewer on dialysis
Associations
- Late nephrology referral -> catheter start, worse outcomes
- Cardiovascular disease - limits ultrafiltration tolerance and drives mortality
- Diabetes - gastroparesis, vascular access difficulty, hypoglycaemia
- Frailty, dementia, malnutrition - shift the balance toward conservative care
- Prior abdominal surgery, hernia, obesity - PD limitations
- Peripheral vascular disease, prior central lines - HD access limitations
- Social circumstances - housing, remoteness, carer support (a dominant issue for Aboriginal and Torres Strait Islander patients requiring relocation from remote communities)
Outcomes
- Once started, dialysis is usually lifelong unless transplanted - AKI-related dialysis is the exception; ~40-60% recover independent function
- Median survival from dialysis start: ~5 years overall; ~2-3 years if aged >75
- Transplantation approximately doubles life expectancy in eligible patients
- Technique failure on PD ~10-15%/yr - peritonitis, ultrafiltration failure, catheter problems -> transfer to HD
- Withdrawal from dialysis accounts for ~10-15% of deaths - revisit goals of care regularly
- Preserving residual renal function improves survival on both modalities and permits an incremental start (e.g. twice-weekly HD)
🔒
12 more sections, plus exam facts
Premium unlocks every note across every specialty, and the full exam fact library behind it.
Get premium access